Status:
UNKNOWN
Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients Hemodynamic
Lead Sponsor:
University of Leipzig
Collaborating Sponsors:
Jena University Hospital
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
16-91 years
Phase:
NA
Brief Summary
Prospective, monocentric open-label observational study for the assessment of acute hemodynamic effects following implantation of the IMPELLA CP cardiac support device
Eligibility Criteria
Inclusion
- Cardiogenic shock following acute MI or acute heart failure with
- systolic BP \< 90 mm Hg over \> 30 min or inotropes for support of cardiac output and BP with
- signs of left heart failure and pulmonary congestion
- and end-organ hypo perfusion with somnolence or cold, pale skin, or oliguria or serum lactate \>2 mmol/l
Exclusion
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04451798
Start Date
December 1 2016
End Date
March 1 2023
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Jena
Jena, Germany, 07747